Noxafil is used to prevent, restrict or stop fungal infections in patients who have severely weakened immune systems, such as the ones who have recently had chemotherapy. It can also be prescribed to treat Candida fungal infections in the mouth or throat.
| Noxafil Brand |
100mg 24 Tablets |
$511.00 | ||
| Noxafil Suspension Brand |
40mg 105 mL |
$321.00 |
Noxafil (generic name: posaconazole) is prescribed to prevent, restrict and treat fungal infections. It is available in three forms – oral suspension (40mg/mL), delayed-release tablets (100mg) and injectable solution (18mg/mL).
Oral suspension is used to treat the fungal infection of the mouth or throat called oral thrush (candidiasis). It may be used either as the initial treatment or after treatment with other antifungal medicines has failed.
Delayed-release tablets are used to treat invasive aspergillosis.
Noxafil is also prescribed to prevent certain yeast or fungus infections such as invasive aspergillus or candida in patients who have a weakened immune system. The reduced immunity may be in hematopoietic stem cell transplant (HSCT) recipients, or patients with blood cancers.
A few side effects have been reported as moderately frequent, and some have severe implications. They should be reported immediately to the prescribing medical health provider or pharmacist:
Less severe side effects include muscle pain, dizziness, difficulty sleeping, low levels of energy, decreased appetite, headaches, coughing, nausea, vomiting or diarrhea. These should be reported to the doctor or pharmacist if they persist or get worse.
More infrequent side effects are:
These side effects should clear up within a few days. If they persist or get worse, consult with your healthcare provider or pharmacist.
Noxafil is prescribed for cases of invasive aspergillus and candida infections in patients who are at high risk of developing these infections due to being severely immunocompromised – for example patients who have been hematopoietic stem cell transplant recipients with acute graft versus host disease (GVHD) or having hematologic malignancies with prolonged neutropenia from chemotherapy. In such cases, the Noxafil oral suspension, tablets or IV may be prescribed.
The duration of the therapy is based on recovery from neutropenia or immunosuppression.
Send Your Prescription
No Hidden Fees
Typically Under 7 days
Are you wondering which drugs are most popular on the IsraelPharm website? Maybe you or someone you know is looking for an alternative source for your prescriptions meds? then read on if you’re curious about
Medical cannabis approval is spreading throughout states in the US and it’s having a big impact on the rate of prescription drug abuse, overdoses and deaths. Surprised? You might think we would be surprised or
Drugs are chemical compounds that break down over time, and expiration dates ensure that you use the medication before this breakdown begins. BUT DON’T FLUSH THEM DOWN THE TOILET
The internet is always a convenient, cheaper alternative to buying consumer products. In recent years, there has been a massive ecommerce boom trumpeting hundreds of website alternatives for any product imaginable that can sell it
An opinion piece on medical marijuana vs. opioid pain killers – by Zachary Goldberg Opioid addiction is a serious problem and despite the DEA’s best efforts it’s only going to get worse. The current restrictions
Erectile dysfunction, also known as ED, is the inability of a man to achieve or maintain an erection sufficient for sexual intercourse through to orgasm. It is a common condition that can affect men of
At this year’s United European Gastroenterology meeting in Italy, Prof. Marco Romano, from the University of Campania in Naples described the results of a new survey, which showed that “Sexual dysfunction (SD) in patients with
September is National Prostate Cancer Awareness Month (also sometimes called just National Prostate Cancer Month – NPCM). It is a month-long campaign founded by the American Urological Association (AUA) to raise awareness about prostate cancer.
